Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726699 · ClinicalTrials.gov registry record
Scripps Tumorgraft Study
A clinical trial of Solid Tumor Malignancy or Hematologic Malignancy, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT01726699 is a study of Solid Tumor Malignancy or Hematologic Malignancy that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01726699, a study of Solid Tumor Malignancy or Hematologic Malignancy, has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.
Conditions Studied
Study Locations (1)
California
- Scripps Translational Science Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01726699
The ClinicalTrials.gov registry entry for NCT01726699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Solid Tumor Malignancy or Hematologic Malignancy appearing as the primary indexed condition, and to 0 interventions.
NCT01726699 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01726699 about?
NCT01726699 is a clinical study titled "Scripps Tumorgraft Study". Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.
What is the current status of trial NCT01726699?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2012-11. Estimated completion is 2014-07.
What conditions does trial NCT01726699 study?
This clinical trial studies the following conditions: Solid Tumor Malignancy or Hematologic Malignancy.
Who is sponsoring clinical trial NCT01726699?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01726699 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.